NOLAXEN
Back to Products25 mg/25 mg
| Form | Tablets coated |
|---|---|
| Active Substance | Spironolactone/Hydrochlorothiazide |
| Presentation | 20 Tablets |
| Treatment Category | Cardiovascular system |
SPC
NOLAXEN
SPC — PDF
CORPORATE
WMR&D
- WMR&D CENTER
- SCIENCE DEPARTMENT
-
PRODUCT DEVELOPMENT AND TECHNOLOGY TRANSFER
- WMINOLAB
BUSINESS STRATEGY
PRESS
-
WORLD MEDICINE IN PRESS
- PRESS RELEASES
- PRESS CENTER
- CORPORATE VIDEOS